Aspira Pathlab & Diagnostics Ltd
BSE:540788
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
51.52
101.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
|
Aspira Pathlab & Diagnostics Ltd
BSE:540788
|
703.8m INR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.4B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
20.3B USD |
Loading...
|
|
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
11B AUD |
Loading...
|
|
| CN |
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
42.2B CNY |
Loading...
|
|
| SE |
|
Medicover AB
STO:MCOV B
|
31B SEK |
Loading...
|
|
| US |
|
Veracyte Inc
NASDAQ:VCYT
|
3B USD |
Loading...
|
|
| DE |
|
Synlab AG
XETRA:SYAB
|
2.4B EUR |
Loading...
|
|
| IN |
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
228.3B INR |
Loading...
|
|
| CN |
|
Dian Diagnostics Group Co Ltd
SZSE:300244
|
15.2B CNY |
Loading...
|
|
| CN |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
14.7B CNY |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
Aspira Pathlab & Diagnostics Ltd
Glance View
Aspira Pathlab & Diagnostics Ltd. engages in the operation of diagnostic centers and laboratories. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2017-12-05. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The firm carries out pathological investigations in various branches, including bio-chemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, other pathological and radiological investigations. The firm's tests include COVID-19 tests, health packages and pathology tests. Its COVID-19 tests include Shanti Screening Test, COVID-19 Antibody Test, COVID-19 Surveillance Profile, COVID-19 RT-PCR Test, COVID-19 Detection Profile 1 and others.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Aspira Pathlab & Diagnostics Ltd is 13.5%, which is above its 3-year median of -1.6%.
Over the last 3 years, Aspira Pathlab & Diagnostics Ltd’s Operating Margin has decreased from 13.7% to 13.5%. During this period, it reached a low of -20.6% on Mar 31, 2024 and a high of 13.7% on Aug 30, 2022.